A professional, data-driven Playwright test framework built with TypeScript. Designed for scalability, maintainability, and ease of use. New here? See QUICKSTART.md for a 5-minute practical guide.
In this tutorial, we build an end-to-end cognitive complexity analysis workflow using complexipy. We start by measuring complexity directly from raw code strings, then scale the same analysis to ...
Data centers have caused the demand for gas-fired power in the US to explode over the past two years, according to new research released Wednesday. More than a third of this new demand, the research ...
Driven by the artificial intelligence frenzy, Microsoft is internally projecting that water use at its data centers will more than double by 2030 from 2020, including in places that face shortages.
AI represents a fundamental shift in how data is leveraged for competitive advantage. Yet, many enterprises are struggling with fragmented systems, siloed data, inconsistent governance and aging ...
Add Yahoo as a preferred source to see more of our stories on Google. A masked U.S. Immigration and Customs Enforcement agent knocks on a car window in Minnesota on Jan. 12. A new court ruling allows ...
Tech giants are in a heated race to build data centers and dominate the AI landscape. But America might not be ready for the energy demand. The country’s aging electrical grid could struggle to keep ...
As the world’s mobile operators transition to software-driven, cloud-native architectures, single-server virtualised RAN (vRAN) deployments are becoming essential, and to allow the providers to meet ...
Jan 13 (Reuters) - Microsoft (MSFT.O), opens new tab on Tuesday unveiled an initiative to curb water usage at its U.S. data centers and limit the impact on the general population from any potential ...
TEL AVIV, Israel, Jan. 12, 2026 /PRNewswire/ -- At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development. LINA is ...
Tech companies are building data centers as quickly as possible to run AI. These facilities are controviersial because they use copious amounts of electricity and might tax an electrical grid that in ...
This marks CytoReason's fifth commercial deal of 2025 and builds on its track record with half of the world's top twenty pharma companies, which have leveraged its technology across a range of ...